CAS 28649-60-7
:4a,7,8-trihydroxy-1,1,3,6-tetramethyl-1a,4a,5,6,7,7a,8,10,11,11a-decahydrospiro[cyclopenta[a]cyclopropa[f][11]annulene-9,2'-oxiran]-4(1H)-one
Description:
The chemical substance known as 4a,7,8-trihydroxy-1,1,3,6-tetramethyl-1a,4a,5,6,7,7a,8,10,11,11a-decahydrospiro[cyclopenta[a]cyclopropa[f][11]annulene-9,2'-oxiran]-4(1H)-one, with the CAS number 28649-60-7, is a complex organic compound characterized by its unique structural features, including multiple hydroxyl groups and a spirocyclic framework. This compound exhibits a high degree of stereochemistry due to its multiple chiral centers, which can influence its reactivity and interactions with biological systems. The presence of hydroxyl groups suggests potential for hydrogen bonding, which may enhance solubility in polar solvents and contribute to its biological activity. Additionally, the oxirane (epoxide) functionality indicates potential for undergoing ring-opening reactions, making it a versatile intermediate in organic synthesis. Its intricate structure may also confer specific pharmacological properties, although detailed studies would be necessary to elucidate its biological effects and potential applications in medicinal chemistry or materials science. Overall, this compound represents a fascinating example of complex organic chemistry with potential implications in various fields.
Formula:C20H30O5
InChI:InChI=1/C20H30O5/c1-10-7-13-12(18(13,3)4)5-6-19(9-25-19)17(23)14-15(21)11(2)8-20(14,24)16(10)22/h7,11-15,17,21,23-24H,5-6,8-9H2,1-4H3/b10-7+
Synonyms:- Epoxylathyrol
- (1Ar,2E,4Ar,6S,7S,7Ar,8S,9R,11As)-1A,4A,5,6,7,7A,8,10,11,11A-Decahydro-4A,7,8-Trihydroxy-1,1,3,6-Tetramethylspiro[9H-Cyclopenta[A]Cyclopropa[F]Cycloundecene-9,2'-Oxiran]-4(1H)-One
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 2 products.
Epoxylathyrol
CAS:Epoxylathyrol derivatives have modulation of ABCB1-mediated multidrug resistance in human colon adenocarcinoma and mouse T-Lymphoma cells.Formula:C20H30O5Purity:98%Color and Shape:SolidMolecular weight:350.455

